Citigroup lowered shares of Leidos (NYSE:LDOS) from a buy rating to a neutral rating in a report released on Tuesday, Benzinga reports. The brokerage currently has $83.00 price target on the aerospace company’s stock, up from their prior price target of $75.00.
Other equities analysts also recently issued reports about the stock. Credit Suisse Group restated a buy rating and issued a $29.00 target price on shares of Clovis Oncology in a research note on Wednesday, May 15th. ValuEngine upgraded shares of VESTAS WIND SYS/ADR from a hold rating to a buy rating in a research note on Thursday, May 9th. Argus upped their target price on shares of Leidos to $82.00 and gave the stock a positive rating in a research note on Thursday, May 16th. Zacks Investment Research downgraded shares of EXACT Sciences from a hold rating to a sell rating in a research note on Tuesday, July 2nd. Finally, Goldman Sachs Group upgraded shares of MICHELIN COMPAG/ADR from a neutral rating to a buy rating in a research note on Thursday, May 9th. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company has an average rating of Buy and an average price target of $80.56.
Leidos stock opened at $81.94 on Tuesday. The company has a debt-to-equity ratio of 0.90, a current ratio of 1.23 and a quick ratio of 1.23. Leidos has a 1-year low of $50.33 and a 1-year high of $82.50. The stock has a market cap of $11.75 billion, a price-to-earnings ratio of 18.71, a P/E/G ratio of 2.36 and a beta of 1.56. The stock has a 50-day moving average price of $78.70.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Friday, June 14th were paid a dividend of $0.32 per share. The ex-dividend date was Thursday, June 13th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 1.56%. Leidos’s dividend payout ratio is presently 29.22%.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in LDOS. Somerset Trust Co boosted its stake in shares of Leidos by 150.6% during the first quarter. Somerset Trust Co now owns 436 shares of the aerospace company’s stock valued at $28,000 after purchasing an additional 262 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. bought a new position in shares of Leidos during the first quarter valued at approximately $32,000. Legacy Advisors LLC bought a new position in shares of Leidos during the first quarter valued at approximately $37,000. Icon Wealth Partners LLC bought a new position in shares of Leidos during the first quarter valued at approximately $37,000. Finally, Bessemer Group Inc. boosted its stake in shares of Leidos by 78.1% during the fourth quarter. Bessemer Group Inc. now owns 896 shares of the aerospace company’s stock valued at $48,000 after purchasing an additional 393 shares in the last quarter. Hedge funds and other institutional investors own 74.62% of the company’s stock.
Leidos Holdings, Inc provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. It operates through three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Further Reading: How to invest in blue-chip stocks
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.